Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes (AIDIT)
2018-002191-41Phase 2Terminated
- Sponsor
- Uppsala University
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of azithromycin in diabetes mellitus type 1 (T1D), sponsored by Uppsala University. Primary endpoint: Residual insulin secretion at 1 year. Started Jul 2018; status: terminated.
02
Drugs
azithromycin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-002191-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002191-41.